| scholarly article | Q13442814 |
| P50 | author | Robin C. Friedman | Q37392070 |
| Michael Icardi | Q74188654 | ||
| P2093 | author name string | Christopher B Burge | |
| Benjamin Kong | |||
| Yulei Wang | |||
| Rebecca T Marquez | |||
| Kyle E Brown | |||
| Warren N Schmidt | |||
| Sarmistha Bandyopadhyay | |||
| Anton P McCaffrey | |||
| Kathy Keck | |||
| P2860 | cites work | Cellular microRNA and P bodies modulate host-HIV-1 interactions | Q37391014 |
| The microRNA network and tumor metastasis | Q37638140 | ||
| Gene expression profiles during hepatic stellate cell activation in culture and in vivo | Q38302031 | ||
| Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma | Q39890346 | ||
| Regulation of the hepatitis C virus genome replication by miR-199a. | Q39895293 | ||
| Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis | Q39953406 | ||
| Renal medullary microRNAs in Dahl salt-sensitive rats: miR-29b regulates several collagens and related genes | Q40302550 | ||
| Determinants of targeting by endogenous and exogenous microRNAs and siRNAs | Q42611158 | ||
| Changes in microRNAs associated with hepatic stellate cell activation status identify signaling pathways | Q43293089 | ||
| Unravelling the importance of microRNAs during hepatitis C virus infection in the human liver | Q45384241 | ||
| Over-expressed microRNA-27a and 27b influence fat accumulation and cell proliferation during rat hepatic stellate cell activation | Q46137385 | ||
| A dual reporter gene transgenic mouse demonstrates heterogeneity in hepatic fibrogenic cell populations. | Q50785680 | ||
| Identification of keratinocyte growth factor as a target of microRNA-155 in lung fibroblasts: implication in epithelial-mesenchymal interactions | Q21562388 | ||
| MicroRNA targeting specificity in mammals: determinants beyond seed pairing | Q24607724 | ||
| MicroRNA-196 represses Bach1 protein and hepatitis C virus gene expression in human hepatoma cells expressing hepatitis C viral proteins | Q24630291 | ||
| The impact of microRNAs on protein output | Q24653549 | ||
| Most mammalian mRNAs are conserved targets of microRNAs | Q24655061 | ||
| Reciprocal Effects of Micro-RNA-122 on Expression of Heme Oxygenase-1 and Hepatitis C Virus Genes in Human Hepatocytes | Q27482654 | ||
| Interferon modulation of cellular microRNAs as an antiviral mechanism | Q27489711 | ||
| Emerging role of microRNAs in liver diseases | Q27490492 | ||
| Human cellular microRNA hsa-miR-29a interferes with viral nef protein expression and HIV-1 replication | Q27497968 | ||
| Prediction of mammalian microRNA targets | Q27860498 | ||
| Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets | Q27860792 | ||
| Complete replication of hepatitis C virus in cell culture | Q27860934 | ||
| Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA | Q27861124 | ||
| Suppression of type I collagen production by microRNA-29b in cultured human stellate cells | Q28117752 | ||
| miR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: An essential role for apoptosis | Q28235822 | ||
| Effects of upregulated expression of microRNA-16 on biological properties of culture-activated hepatic stellate cells | Q28259784 | ||
| Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2 | Q28295844 | ||
| Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets | Q28303698 | ||
| miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling | Q28304542 | ||
| MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts | Q28511032 | ||
| LNA-mediated microRNA silencing in non-human primates | Q29615962 | ||
| Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis | Q29619873 | ||
| Computational identification of hepatitis C virus associated microRNA-mRNA regulatory modules in human livers | Q33492595 | ||
| Liver fibrosis causes downregulation of miRNA-150 and miRNA-194 in hepatic stellate cells, and their overexpression causes decreased stellate cell activation | Q33588984 | ||
| Broad-spectrum matrix metalloproteinase inhibition curbs inflammation and liver injury but aggravates experimental liver fibrosis in mice | Q33622449 | ||
| Loss of MicroRNA-192 promotes fibrogenesis in diabetic nephropathy | Q33702426 | ||
| Systematic identification of microRNA and messenger RNA profiles in hepatitis C virus-infected human hepatoma cells | Q34087743 | ||
| Roles of TGF-beta in hepatic fibrosis | Q34565570 | ||
| Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. | Q34742406 | ||
| MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma | Q34756477 | ||
| Distribution of organelles and membranes between hepatocytes and nonhepatocytes in the rat liver parenchyma. A stereological study | Q36202591 | ||
| Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation | Q37257324 | ||
| TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN | Q37347217 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatitis C | Q154869 |
| Hepatitis C virus | Q708693 | ||
| overexpression | Q61643320 | ||
| P304 | page(s) | 1753-1762 | |
| P577 | publication date | 2011-06-01 | |
| P1433 | published in | Journal of Infectious Diseases | Q4051141 |
| P1476 | title | Hepatitis C virus infection and hepatic stellate cell activation downregulate miR-29: miR-29 overexpression reduces hepatitis C viral abundance in culture | |
| P478 | volume | 203 |
| Q35547227 | A computational approach to identifying gene-microRNA modules in cancer |
| Q37584479 | A microRNA network regulates proliferative timing and extracellular matrix synthesis during cellular quiescence in fibroblasts. |
| Q37252581 | Achieving sustained virologic response after interferon-free hepatitis C virus treatment correlates with hepatic interferon gene expression changes independent of cirrhosis |
| Q35754727 | Activation of Mir-29a in Activated Hepatic Stellate Cells Modulates Its Profibrogenic Phenotype through Inhibition of Histone Deacetylases 4. |
| Q37403072 | Apoptosis and necrosis in the liver |
| Q64113821 | Baseline Hepatic Levels of miR-29b and Claudin are Respectively Associated with the Stage of Fibrosis and HCV RNA in Hepatitis C |
| Q35628167 | Circulating microRNA-196a as a candidate diagnostic biomarker for chronic hepatitis C. |
| Q58789593 | Circulating microRNA-636 is associated with the elimination of hepatitis C virus by ombitasvir/paritaprevir/ritonavir |
| Q34302987 | Complex interactions between microRNAs and hepatitis B/C viruses |
| Q64068390 | Diffusion-weighted magnetic resonance imaging and micro-RNA in the diagnosis of hepatic fibrosis in chronic hepatitis C virus |
| Q38985933 | Epigenetic regulation of hepatic stellate cell activation and liver fibrosis |
| Q39310726 | Epigenetic regulation of miR-124 by hepatitis C virus core protein promotes migration and invasion of intrahepatic cholangiocarcinoma cells by targeting SMYD3. |
| Q84079602 | Expression of platelet-derived growth factor-C and insulin-like growth factor I in hepatic stellate cells is inhibited by miR-29 |
| Q42229509 | Genome-wide mRNA and miRNA analysis of peripheral blood mononuclear cells (PBMC) reveals different miRNAs regulating HIV/HCV co-infection |
| Q26752932 | Hepatic Stellate Cells and microRNAs in Pathogenesis of Liver Fibrosis |
| Q92538283 | Hepatitis C Virus Mediated Inhibition of miR-181c Activates ATM Signaling and Promotes Hepatocyte Growth |
| Q37481988 | Hepatitis C Virus and HIV Type 1 Co-Infection |
| Q40634326 | Hepatitis C virus infection stimulates transforming growth factor-β1 expression through up-regulating miR-192. |
| Q37196517 | Hepatitis C virus infection, microRNA and liver disease progression |
| Q35650384 | Heroin use promotes HCV infection and dysregulates HCV-related circulating microRNAs |
| Q37123557 | High-throughput profiling of alpha interferon- and interleukin-28B-regulated microRNAs and identification of let-7s with anti-hepatitis C virus activity by targeting IGF2BP1. |
| Q38902559 | Immune regulation in chronic hepatitis C virus infection |
| Q27303171 | Isolation of human salivary extracellular vesicles by iodixanol density gradient ultracentrifugation and their characterizations |
| Q90724782 | Mechanisms Underlying Hepatitis C Virus-Associated Hepatic Fibrosis |
| Q38754395 | MiR-29a Assists in Preventing the Activation of Human Stellate Cells and Promotes Recovery From Liver Fibrosis in Mice |
| Q21560965 | Micro-RNA profiling in human serum reveals compartment-specific roles of miR-571 and miR-652 in liver cirrhosis |
| Q35202304 | MicroRNA and hepatitis C virus--challenges in investigation and translation: a review of the literature |
| Q33907481 | MicroRNA function in the profibrogenic interplay upon chronic liver disease |
| Q35690705 | MicroRNA profiling identifies miR-29 as a regulator of disease-associated pathways in experimental biliary atresia |
| Q59350529 | MicroRNA-135a Modulates Hepatitis C Virus Genome Replication through Downregulation of Host Antiviral Factors |
| Q38193005 | MicroRNA-155 and microRNA-196b: promising biomarkers in hepatitis C virus infection? |
| Q36759971 | MicroRNA-27a regulates lipid metabolism and inhibits hepatitis C virus replication in human hepatoma cells |
| Q42323197 | MicroRNA-29a Alleviates Bile Duct Ligation Exacerbation of Hepatic Fibrosis in Mice through Epigenetic Control of Methyltransferases. |
| Q61809503 | MicroRNA-29a is a key regulon that regulates BRD4 and mitigates liver fibrosis in mice by inhibiting hepatic stellate cell activation |
| Q57154331 | MicroRNA-29a protects against acute liver injury in a mouse model of obstructive jaundice via inhibition of the extrinsic apoptosis pathway |
| Q39062871 | MicroRNA-29b modulates Japanese encephalitis virus-induced microglia activation by targeting tumor necrosis factor alpha-induced protein 3. |
| Q26773254 | MicroRNA-mediated interactions between host and hepatitis C virus |
| Q64257685 | MicroRNA29a Reverts the Activated Hepatic Stellate Cells in the Regression of Hepatic Fibrosis through Regulation of ATPase H⁺ Transporting V1 Subunit C1 |
| Q26773183 | MicroRNAs Expressed during Viral Infection: Biomarker Potential and Therapeutic Considerations |
| Q38018170 | MicroRNAs and hepatitis C virus: toward the end of miR-122 supremacy |
| Q26765476 | MicroRNAs as Biomarkers for Liver Disease and Hepatocellular Carcinoma |
| Q37613598 | MicroRNAs in Liver Disease: Bench to Bedside |
| Q38802349 | MicroRNAs, HIV and HCV: a complex relation towards pathology. |
| Q27015778 | MicroRNAs, hepatitis C virus, and HCV/HIV-1 co-infection: new insights in pathogenesis and therapy |
| Q35606627 | MicroRNAs: Role in Hepatitis C Virus pathogenesis |
| Q36743589 | Microarray Study of Pathway Analysis Expression Profile Associated with MicroRNA-29a with Regard to Murine Cholestatic Liver Injuries. |
| Q26768588 | Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis |
| Q90441154 | RNA Sequencing revealed differentially expressed genes functionally associated with immunity and tumor suppression during latent phase infection of a vv + MDV in chickens |
| Q37346014 | RNA viruses and microRNAs: challenging discoveries for the 21st century. |
| Q36515468 | Regulation of human RNase-L by the miR-29 family reveals a novel oncogenic role in chronic myelogenous leukemia |
| Q48091665 | Regulation of insulin resistance and type II diabetes by hepatitis C virus infection: A driver function of circulating miRNAs |
| Q36997713 | Regulation of viral oncogenesis by microRNAs |
| Q92574930 | Role of Preoperative Viral Load and Presence of Hepatocellular Carcinoma in the Biliary Complications After Liver Transplantation Due to Hepatitis C Virus |
| Q40494880 | Roles of bta-miR-29b promoter regions DNA methylation in regulating miR-29b expression and bovine viral diarrhea virus NADL replication in MDBK cells |
| Q43427874 | Serum microRNA expression profile as a biomarker for the diagnosis of pertussis |
| Q40486075 | Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection |
| Q42199097 | Serum microRNA-29 levels correlate with disease progression in patients with chronic hepatitis B virus infection |
| Q41921194 | The Clinical Application of MicroRNAs in Infectious Disease |
| Q36969738 | The Liver MicroRNA Expression Profiles Associated With Chronic Hepatitis C Virus (HCV) Genotype-4 Infection: A Preliminary Study |
| Q64941956 | The Role of miR-29a in the Regulation, Function, and Signaling of Liver Fibrosis. |
| Q47553075 | The Role of miRNAs in the Pathophysiology of Liver Diseases and Toxicity |
| Q43434035 | The circulatory orbit of micro-RNAs in hepatitis C. |
| Q35055339 | The role of miRNAs in the regulation of inflammatory processes during hepatofibrogenesis |
| Q42259914 | The role of microRNAs in hepatitis C virus RNA replication |
| Q38215700 | The role of microRNAs in hepatitis C virus replication and related liver diseases |
| Q40548291 | Toll-like receptor 3-activated macrophages confer anti-HCV activity to hepatocytes through exosomes |
| Q38981269 | bta-miR-29b attenuates apoptosis by directly targeting caspase-7 and NAIF1 and suppresses bovine viral diarrhea virus replication in MDBK cells |
| Q35819563 | miR-122 negatively correlates with liver fibrosis as detected by histology and FibroScan |
| Q42995019 | miR-1273g-3p modulates activation and apoptosis of hepatic stellate cells by directly targeting PTEN in HCV-related liver fibrosis |
| Q37578279 | miR-29a Promotes Lipid Droplet and Triglyceride Formation in HCV Infection by Inducing Expression of SREBP-1c and CAV1. |
| Q34179800 | miR-29a suppresses growth and invasion of gastric cancer cells in vitro by targeting VEGF-A. |
| Q45344075 | miR-29a-3p suppresses cell proliferation and migration by downregulating IGF1R in hepatocellular carcinoma |
| Q34163429 | microRNA levels in paraffin-embedded indolent B-cell non-Hodgkin lymphoma tissues from patients chronically infected with hepatitis B or C virus |
Search more.